Cargando…

Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer

PURPOSE: Prostate-specific membrane antigen (PSMA) targeting therapies such as Lutetium-177 (177Lu)–PSMA-617 are affecting outcomes from metastatic castration-resistant prostate cancer (mCRPC). However, a significant subset of patients have prostate cancer cells lacking PSMA expression, raising conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheehan, Beshara, Neeb, Antje, Buroni, Lorenzo, Paschalis, Alec, Riisnaes, Ruth, Gurel, Bora, Gil, Veronica, Miranda, Susana, Crespo, Mateus, Guo, Christina, Jiménez Vacas, Juan, Figueiredo, Ines, Ferreira, Ana, Welti, Jon, Yuan, Wei, Carreira, Suzanne, Sharp, Adam, de Bono, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365343/
https://www.ncbi.nlm.nih.gov/pubmed/35552383
http://dx.doi.org/10.1158/1078-0432.CCR-21-4531